VEGFA and ocular hypertension: A retrospective study estimated the risk of glaucoma or sustained ocular hypertension related to anti-VEGF treatment for neovascular AMD, and found that the rate of injection and lens status are associated with intraocular pressure (Wingard et al., 2019).